SCHEMBL30005835

SCHEMBL30005835

CN(c1ccccc1C(=O)Nc1ccc(S(=O)(=O)N2CCN(c3cc(Cl)cc(OCCNC(=O)OC(C)(C)C)c3)CC2)cc1)S(C)(=O)=O

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.43
PTGDR Q13258 2/20 0.43
POLB P06746 3/20 0.42
TSHR P16473 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
MERTK Q12866 1/20 0.41
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40
BLM P54132 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30005031 0.92 ALDH1A1 (0.55) ALDH1A1KMT2AMEN1NPSR1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL30006682 0.85 ALDH1A1 (0.55) ALDH1A1KMT2AMEN1NPSR1SMN1; SMN2
SCHEMBL30005662 0.85 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1NPSR1L3MBTL1
SCHEMBL30005465 0.84 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1NPSR1SMN1; SMN2
SCHEMBL30005563 0.83 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1NPSR1SMN1; SMN2
SCHEMBL30005509 0.82 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1NPSR1MERTK
SCHEMBL30006406 0.82 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1NPSR1SMN1; SMN2
SCHEMBL30005575 0.82 ALDH1A1 (0.42) ALDH1A1KMT2AMEN1NPSR1PTGDR
SCHEMBL30006437 0.81 ALDH1A1 (0.68) ALDH1A1KMT2AMEN1NPSR1SMN1; SMN2
SCHEMBL30006454 0.80 ALDH1A1 (0.67) ALDH1A1KMT2AMEN1NPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022220725-A1 LPXH INHIBITORS AS ANTI-INFECTIVE AGENTS ZAMARATSKI EDOUARD (SE) 2022-10-20 WO disclosed